Export Ready — 

Bioactivities and extract dereplication of actinomycetales isolated from marine sponges

Bibliographic Details
Main Author: Santos, J.D.
Publication Date: 2019
Other Authors: Vitorino, I., De La Cruz, M., Díaz, C., Cautain, B., Annang, F., Pérez-Moreno, G., Martinez, I.G., Tormo, J.R., Martín, J.M., Urbatzka, R., Vicente, F.M., Lage O.M.
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://hdl.handle.net/10216/130472
Summary: In the beginning of the twenty-first century, humanity faces great challenges regarding diseases and health-related quality of life. A drastic rise in bacterial antibiotic resistance, in the number of cancer patients, in the obesity epidemics and in chronic diseases due to life expectation extension are some of these challenges. The discovery of novel therapeutics is fundamental and it may come from underexplored environments, like marine habitats, and microbial origin. Actinobacteria are well-known as treasure chests for the discovery of novel natural compounds. In this study, eighteen Actinomycetales isolated from marine sponges of three Erylus genera collected in Portuguese waters were tested for bioactivities with the main goal of isolating and characterizing the responsible bioactive metabolites. The screening comprehended antimicrobial, anti-fungal, anti-parasitic, anti-cancer and anti-obesity properties. Fermentations of the selected strains were prepared using ten different culturing media. Several bioactivities against the fungus Aspergillus fumigatus, the bacteria Staphylococcus aureus methicillin-resistant (MRSA) and the human liver cancer cell line HepG2 were obtained in small volume cultures. Screening in higher volumes showed consistent anti-fungal activity by strain Dermacoccus sp. #91-17 and Micrococcus luteus Berg02-26. Gordonia sp. Berg02-22.2 showed anti-parasitic (Trypanosoma cruzi) and anti-cancer activity against several cell lines (melanoma A2058, liver HepG2, colon HT29, breast MCF7 and pancreatic MiaPaca). For the anti-obesity assay, Microbacterium foliorum #91-29 and #91-40 induced lipid reduction on the larvae of zebrafish (Danio rerio). Dereplication of the extracts from several bacteria showed the existence of a variety of secondary metabolites, with some undiscovered molecules. This work showed that Actinomycetales are indeed good candidates for drug discovery.
id RCAP_8a9e0bf78d90266f7f20d587eece26d5
oai_identifier_str oai:repositorio-aberto.up.pt:10216/130472
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Bioactivities and extract dereplication of actinomycetales isolated from marine spongesActinomycetalesAnti-cancerAnti-obesogenicAnti-parasiticAntimicrobialsMarine spongesIn the beginning of the twenty-first century, humanity faces great challenges regarding diseases and health-related quality of life. A drastic rise in bacterial antibiotic resistance, in the number of cancer patients, in the obesity epidemics and in chronic diseases due to life expectation extension are some of these challenges. The discovery of novel therapeutics is fundamental and it may come from underexplored environments, like marine habitats, and microbial origin. Actinobacteria are well-known as treasure chests for the discovery of novel natural compounds. In this study, eighteen Actinomycetales isolated from marine sponges of three Erylus genera collected in Portuguese waters were tested for bioactivities with the main goal of isolating and characterizing the responsible bioactive metabolites. The screening comprehended antimicrobial, anti-fungal, anti-parasitic, anti-cancer and anti-obesity properties. Fermentations of the selected strains were prepared using ten different culturing media. Several bioactivities against the fungus Aspergillus fumigatus, the bacteria Staphylococcus aureus methicillin-resistant (MRSA) and the human liver cancer cell line HepG2 were obtained in small volume cultures. Screening in higher volumes showed consistent anti-fungal activity by strain Dermacoccus sp. #91-17 and Micrococcus luteus Berg02-26. Gordonia sp. Berg02-22.2 showed anti-parasitic (Trypanosoma cruzi) and anti-cancer activity against several cell lines (melanoma A2058, liver HepG2, colon HT29, breast MCF7 and pancreatic MiaPaca). For the anti-obesity assay, Microbacterium foliorum #91-29 and #91-40 induced lipid reduction on the larvae of zebrafish (Danio rerio). Dereplication of the extracts from several bacteria showed the existence of a variety of secondary metabolites, with some undiscovered molecules. This work showed that Actinomycetales are indeed good candidates for drug discovery.Frontiers in Microbiology20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/130472engISSN 1664-302Xhttps://doi.org/10.3389/fmicb.2019.00727Santos, J.D.Vitorino, I.De La Cruz, M.Díaz, C.Cautain, B.Annang, F.Pérez-Moreno, G.Martinez, I.G.Tormo, J.R.Martín, J.M.Urbatzka, R.Vicente, F.M.Lage O.M.info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-27T19:52:05Zoai:repositorio-aberto.up.pt:10216/130472Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T23:35:41.203293Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Bioactivities and extract dereplication of actinomycetales isolated from marine sponges
title Bioactivities and extract dereplication of actinomycetales isolated from marine sponges
spellingShingle Bioactivities and extract dereplication of actinomycetales isolated from marine sponges
Santos, J.D.
Actinomycetales
Anti-cancer
Anti-obesogenic
Anti-parasitic
Antimicrobials
Marine sponges
title_short Bioactivities and extract dereplication of actinomycetales isolated from marine sponges
title_full Bioactivities and extract dereplication of actinomycetales isolated from marine sponges
title_fullStr Bioactivities and extract dereplication of actinomycetales isolated from marine sponges
title_full_unstemmed Bioactivities and extract dereplication of actinomycetales isolated from marine sponges
title_sort Bioactivities and extract dereplication of actinomycetales isolated from marine sponges
author Santos, J.D.
author_facet Santos, J.D.
Vitorino, I.
De La Cruz, M.
Díaz, C.
Cautain, B.
Annang, F.
Pérez-Moreno, G.
Martinez, I.G.
Tormo, J.R.
Martín, J.M.
Urbatzka, R.
Vicente, F.M.
Lage O.M.
author_role author
author2 Vitorino, I.
De La Cruz, M.
Díaz, C.
Cautain, B.
Annang, F.
Pérez-Moreno, G.
Martinez, I.G.
Tormo, J.R.
Martín, J.M.
Urbatzka, R.
Vicente, F.M.
Lage O.M.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Santos, J.D.
Vitorino, I.
De La Cruz, M.
Díaz, C.
Cautain, B.
Annang, F.
Pérez-Moreno, G.
Martinez, I.G.
Tormo, J.R.
Martín, J.M.
Urbatzka, R.
Vicente, F.M.
Lage O.M.
dc.subject.por.fl_str_mv Actinomycetales
Anti-cancer
Anti-obesogenic
Anti-parasitic
Antimicrobials
Marine sponges
topic Actinomycetales
Anti-cancer
Anti-obesogenic
Anti-parasitic
Antimicrobials
Marine sponges
description In the beginning of the twenty-first century, humanity faces great challenges regarding diseases and health-related quality of life. A drastic rise in bacterial antibiotic resistance, in the number of cancer patients, in the obesity epidemics and in chronic diseases due to life expectation extension are some of these challenges. The discovery of novel therapeutics is fundamental and it may come from underexplored environments, like marine habitats, and microbial origin. Actinobacteria are well-known as treasure chests for the discovery of novel natural compounds. In this study, eighteen Actinomycetales isolated from marine sponges of three Erylus genera collected in Portuguese waters were tested for bioactivities with the main goal of isolating and characterizing the responsible bioactive metabolites. The screening comprehended antimicrobial, anti-fungal, anti-parasitic, anti-cancer and anti-obesity properties. Fermentations of the selected strains were prepared using ten different culturing media. Several bioactivities against the fungus Aspergillus fumigatus, the bacteria Staphylococcus aureus methicillin-resistant (MRSA) and the human liver cancer cell line HepG2 were obtained in small volume cultures. Screening in higher volumes showed consistent anti-fungal activity by strain Dermacoccus sp. #91-17 and Micrococcus luteus Berg02-26. Gordonia sp. Berg02-22.2 showed anti-parasitic (Trypanosoma cruzi) and anti-cancer activity against several cell lines (melanoma A2058, liver HepG2, colon HT29, breast MCF7 and pancreatic MiaPaca). For the anti-obesity assay, Microbacterium foliorum #91-29 and #91-40 induced lipid reduction on the larvae of zebrafish (Danio rerio). Dereplication of the extracts from several bacteria showed the existence of a variety of secondary metabolites, with some undiscovered molecules. This work showed that Actinomycetales are indeed good candidates for drug discovery.
publishDate 2019
dc.date.none.fl_str_mv 2019
2019-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/130472
url https://hdl.handle.net/10216/130472
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv ISSN 1664-302X
https://doi.org/10.3389/fmicb.2019.00727
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers in Microbiology
publisher.none.fl_str_mv Frontiers in Microbiology
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833600217605210112